Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Standard test method used (OECD test guidelne) GLP statement

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1,2,3,6-tetrahydrophthalimide
EC Number:
201-602-8
EC Name:
1,2,3,6-tetrahydrophthalimide
Cas Number:
85-40-5
Molecular formula:
C8H9NO2
IUPAC Name:
2,3,3a,4,7,7a-hexahydro-1H-isoindole-1,3-dione
Details on test material:
- Name of test material (as cited in study report): P2008
- Analytical purity: 97.70%
- Impurities (identity and concentrations): Tetrahydrophthalic anhydride D3 - 0.02%; Tetrahydrophthalic anhydride D4 - 0.05%;
Tetrahydrophthalimide D3 - 1.48%; Tetrahydrophthalimide D4 isomer - 0.75%
- Lot/batch No.: 1801

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (UK) Limited, Manston, Kent, England
- Age at study initiation: 6-9 weeks
- Weight at study initiation:
- Fasting period before study: Overnight
- Housing: 5/sex/cage
- Diet (e.g. ad libitum): Conventional laboratory diet (Rat and Mouse No. 1 expanded; Special Diet Services Limited) fed ad libitum except for overnight fast before dosing and approximately 2 hours following dosing
- Water (e.g. ad libitum): Municipal mains water available ad libitum
- Acclimation period: Minimum of 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-24
- Humidity (%): 34-84
- Air changes (per hr): Approximately 15
- Photoperiod (hrs dark / hrs light): 12/12


IN-LIFE DATES: From: 1991-01-15 To: 1991-02-28

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
arachis oil
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 500 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg


MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg


Doses:
5000 mg/kg
No. of animals per sex per dose:
5 males / 5 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations 30 minutes, 1, 2 and 4 hours after dosing then daily for 14 days. Body weights recorded on day of dosing (Day 0) and at weekly intervals during post-dose observation period (Days 7 and 14)
- Necropsy of survivors performed: yes
Statistics:
None

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
approximate LD50
Effect level:
> 5 000 mg/kg bw
Mortality:
One of 5 males and 1 of 5 females died within 24 hours of dosing (See Table 1 for details)
Clinical signs:
other: Lethargy, hunched posure, ataxia, ptosis, laboured respiration and loss of righting reflex noted following dosing. Surviving animals had generally recovered within 24 hours of dosing (See Table 1 for details)
Gross pathology:
No abnormal findings in surviving animals
Animals that died showed changes to the lungs, liver and kidneys that were possibly agonal in nature.
Haemorrhaging noted in regions of the stomach, small and large intestines noted (See Table 2 for details)

Any other information on results incl. tables

Table 1: Clinical findings / mortality 

 

Dose

Animal

Clinical signs / Mortality

level

Sex

number

Hours

Days

(mg/kg)

 

 

0.5

1

2

4

 

1

2-14

5-0

0

0

HLPtA

HLPtRlA

X

-

5-1

0

0

L

L

0

0

Male

5-2

0

0

L

L

0

0

5-3

0

0

L

L

0

0

5-4

0

0

L

L

0

0

5000

6-0

0

0

LPt

HLPt

H

0

6-1

0

0

HL

HLPt

0

0

Female

6-2

0

0

L

0

0

0

6-3

0

0

0

0

0

0

 

 

6-4

LA

LPtRr

X

-

 

-

-

Key:

0 : No signs of toxicity

H : Hunched posture

L : Lethargy

A : Ataxia

Pt : Ptosis

Rl : Laboured respiration

Rr : Loss of righting reflex

X : Animal dead

Table 2: Necropsy findings

 

Dose level

Sex

Animal

Day of death

Macroscopic observations at necropsy

(mg/kg)

_

_

_

_

5-0

Died Day 1

Lungs: haemorrhagic

Liver: dark

Kidneys: dark

Stomach: epithelial sloughing from glandular and non-glandular regions

Small intestine: haemorrhagic

Large intestine: haemorrhagic

5-1

Terminal kill

No abnormalities noted

Male

5-2

Terminal kill

No abnormalities noted

5-3

Terminal kill

No abnormalities noted

5-4

Terminal kill

No abnormalities noted

5000

6-0

Terminal kill

No abnormalities noted

6-1

Terminal kill

No abnormalities noted

Female

6-2

Terminal kill

No abnormalities noted

6-3

Terminal kill

No abnormalities noted

6-4

Died Day 0

Lungs: abnormally red

Liver: dark

Stomach: glandular region haemorrhagic

 

 

 

 

Small intestine: haemorrhagic

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU